Informations sur le stock Evonik | Filter  Basic-Info

Evonik

Evonik mainly operates in the chemical sector. The global chemical companies gained around 72 percent worldwide over the last 10 years. Measured since 2011 the sector is 20 percent higher and over the past 12 months (December 2015-December 2016) there is a minus of 72 percent.

The past year was a good year for Evonik investors

Over the past year the company' stock lost around 4 percent. Over the period from December 2011 till December 2016 the stock lost on average 0 percent. Evonik's revenues between 2011 and 2015 were very constant and moved between 13,37 billion euros and 13,51 billion euros. Evonik's net incomes between 2011 and 2015 were quiet stable and moved between 1,01 billion euros and 1,13 billion euros.

The German company paid out dividends in the past 5 years. Over the past 5 years Evonik's dividend yield was at around 4,06 percent per year.

The German company had ultimo 2015 approximately 33,41 thousand employees on it's payroll.

Evonik financed with relatively low debt

As per the end of 2015 the German company's balance sheet equaled 17,01 billion euros. Of the total balance sheet 9,43 billion euros (55,45 percent) was financed by debt. The German company's price/earnings-ratio was 13. So the market valued the stock at 13 times the 2015' earnings per share. We could say that based on her price/earnings-ratio and dividend yield the German stock can be seen as a value stock.

At the end of 2015 the market capitalization (the number of shares outstanding multiplied by the stock price) of the chemical company equaled around 13,86 billion euros. At the end of 2015 the German company had around 466 million stocks listed.

All Evonik's annual reports can be found here. More information about Evonik can be found it's website. .